| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/17/2006 | CN1256102C Powder for treating hyperosteogeny and protrusion of lumber and spondylopathy intervertebral disc and its preparation |
| 05/17/2006 | CN1256101C Method for preparing novel anti-cancer medicine |
| 05/17/2006 | CN1256094C 3'-Deoxyadenosine in application of preparing bypolipidemic |
| 05/17/2006 | CN1256093C Application of skimming in the preparing process of medicine for preventing and treating kidney function failure |
| 05/17/2006 | CN1256092C Methyleritrocina injection |
| 05/17/2006 | CN1256091C Adriacin or adriacin hydrochloride liposome injection and its preparing process |
| 05/17/2006 | CN1256088C 维生素c钠胶囊 Vitamin c sodium capsules |
| 05/17/2006 | CN1256085C Sertraline salts and substained-release dosage forms of sertraline |
| 05/17/2006 | CN1256083C Medicine for boosting qi and nourishing blood, its prepatation method and application |
| 05/17/2006 | CN1256082C Slow-released preparation |
| 05/17/2006 | CN1256081C Method for preparing injection of oleum functus brucease |
| 05/17/2006 | CN1256080C In-situ gel formation of pectins |
| 05/17/2006 | CN1256043C Method for producing oyster tablet by adding oyster shell superfine powder |
| 05/16/2006 | US7047070 Valved intradermal delivery device and method of intradermally delivering a substance to a patient |
| 05/16/2006 | US7045643 Method for obtaining novel lutein-based formulations |
| 05/16/2006 | US7045601 Complexing with metal compound and complexing agent |
| 05/16/2006 | US7045589 Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
| 05/16/2006 | US7045552 Aqueous formulation of fusion inhibitor and polyol; minimizes number of injections and site reaction |
| 05/16/2006 | US7045550 In situ administering; side effect reduction of cancer therapy |
| 05/16/2006 | US7045546 Stabilized derivatives of ascorbic acid-3-phosphate |
| 05/16/2006 | US7045543 Insertion drugs into cells, tissue; therapy for brain disorders, central nervous system disorders |
| 05/16/2006 | US7045511 Fosinopril formulation |
| 05/16/2006 | US7045500 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 05/16/2006 | US7045323 Glutathione reductase for therapy and prophylaxis of aids |
| 05/16/2006 | US7045283 Detecting preferential ligands in cell; obtain cell, incubate with reporter molecules, detect reporter in cell |
| 05/16/2006 | US7045184 Polyvinyl alcohol and a setting system which may be hydrocolloids and cations; optionally sequestering agents; soft and hard capsules |
| 05/16/2006 | US7045155 Phytooestrogen selected from genistein, daidzein; for promoting health in cases of cancer, pre-menstrual syndrome, menopause or hypercholesterolaemia |
| 05/16/2006 | US7045152 Pulmonary disorders in which the S-nitrosoglutathione(GSNO) pool or glutathione pool in the lung is depleted and where reactive oxygen species in lung are increased, are treated by delivering into the lung an agent causing repletion of GSNO |
| 05/16/2006 | US7045147 Therapy for congestive heart failure; administering by mouth |
| 05/16/2006 | US7045146 Treating the solid particle material with an amphiphilic substance and coating the material with a layer of a charged polyelectrolyte or with a multilayer comprising alternating layers of oppositely charged polyelectrolytes. |
| 05/16/2006 | US7045145 Multilayer; backing layer, solid absorption adhesive polymer matrix ; controlled dosage of estrogen and progestin |
| 05/16/2006 | US7045144 Plaster containing an active agent |
| 05/16/2006 | US7045143 Mixture of lecithin and fatty acid; antiinflammatory agents; diseases of lipid metabolism; immunology disorders |
| 05/16/2006 | US7045140 Therapeutic delivery of carbon monoxide |
| 05/16/2006 | US7045137 Skin cleaning while maintaining moisture; aqueous solution containing sugar and fruit extracts |
| 05/16/2006 | US7045121 Ophthalmic compositions for lubricating eyes and methods for making and using same |
| 05/16/2006 | US7045119 Delivery of diazepam through an inhalation route |
| 05/16/2006 | US7045118 Delivery of compounds for the treatment of migraine through an inhalation route |
| 05/16/2006 | US7045095 Use of low molecular weight amino alcohols in ophthalmic compositions |
| 05/16/2006 | US7044942 Implantable fluid delivery apparatuses and implantable electrode |
| 05/16/2006 | CA2366856C Formulation comprising testosteron undecanoate and castor oil |
| 05/16/2006 | CA2291274C Uses of oil bodies |
| 05/16/2006 | CA2273509C Aerosol device with base of fixing material alcoholic compositions containing anionic grafted siliconized polymers |
| 05/12/2006 | CA2487564A1 Folic acid-chitosan-dna nanoparticles |
| 05/11/2006 | WO2006050533A2 Stabilized individually coated ramipril particles, compositions and methods |
| 05/11/2006 | WO2006050514A1 Gabapentin prodrug sustained release oral dosage forms |
| 05/11/2006 | WO2006050327A2 Lyophilized liposome formulations and method |
| 05/11/2006 | WO2006050315A2 Aliphatic amine polymer salts for tableting |
| 05/11/2006 | WO2006050303A2 Intravaginal treatment of vaginal infections with metronidazole compositions |
| 05/11/2006 | WO2006050302A2 Dye-free pharmaceutical suspensions and related methods |
| 05/11/2006 | WO2006050301A2 Dye-free pharmaceutical suspensions and related methods |
| 05/11/2006 | WO2006050246A2 Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles, their manufacturing and their use for diagnostics and therapy |
| 05/11/2006 | WO2006050165A2 Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis |
| 05/11/2006 | WO2006050123A1 Spontaneously dispersible pharmaceutical compositions |
| 05/11/2006 | WO2006050116A1 Methods of cancer treatment/prevention using cancer cell-specific surface antigens |
| 05/11/2006 | WO2006050101A1 Dye-free pharmaceutical suspensions comprising sorbitol as a non-reducing sweetener and at least one active agent |
| 05/11/2006 | WO2006050072A2 Manufacturing process for liposomal preparations |
| 05/11/2006 | WO2006049683A1 Immediate release film coating |
| 05/11/2006 | WO2006049565A1 New modified release tablet formulations for proton pump inhibitors |
| 05/11/2006 | WO2006049564A1 New modified release pellet formulations for proton pump inhibitors |
| 05/11/2006 | WO2006049307A1 Liposome and method of injecting substance into cell by using the same |
| 05/11/2006 | WO2006049078A1 Drug for external use for treating skin disease |
| 05/11/2006 | WO2006048895A1 Aqueous pharmaceutical coating |
| 05/11/2006 | WO2006048773A1 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation |
| 05/11/2006 | WO2006048772A2 Reverse micelles based on phytosterols and acylglycerols and therapeutic uses thereof |
| 05/11/2006 | WO2006048639A1 Hydrogel delivery vehicle |
| 05/11/2006 | WO2006048601A1 Thermally responsive polymers |
| 05/11/2006 | WO2006048501A1 A transmucosal veterinary composition comprising detomidine |
| 05/11/2006 | WO2006048329A1 Improvements in or relating to pharmaceutical compositions comprising an oligonucleotide as an active agent |
| 05/11/2006 | WO2006048321A1 Multimodally modified cells used as an administrable form for active substances and as diagnostic particles |
| 05/11/2006 | WO2006048261A2 Oral solid dosage forms containing a low dose of estradiol |
| 05/11/2006 | WO2006048208A1 Bilayer tablet comprising telmisartan and amlodipine |
| 05/11/2006 | WO2006048017A1 Lipid-based drug delivery systems containing unnatural phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof |
| 05/11/2006 | WO2006047988A1 Anisometric particles in the form of nanofibers/mesofibers, nanopipes/mesopipes, nanocables/mesocables, nanobands/mesobands, and the curved or branched variations thereof |
| 05/11/2006 | WO2006047949A1 The use of human urinary kallidinogenase for the manufacture of a medicine for the treatment of acute coronary syndromes |
| 05/11/2006 | WO2006047948A1 The use of human urinary kallidinogenase for the manufacture of a medicine for the treatment of sepsis |
| 05/11/2006 | WO2006047931A1 The use of dipyridamole in manufacturing the anti-malignant tumor medicines |
| 05/11/2006 | WO2006047872A1 Bacteriophage compositions |
| 05/11/2006 | WO2006047871A1 Encapsulated bacteriophage formulation |
| 05/11/2006 | WO2006035414A3 Carbidopa and levodopa dispersible tablets |
| 05/11/2006 | WO2006031720A3 D-methionine formulation with improved biopharmaceutical properties |
| 05/11/2006 | WO2006030450A3 Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy |
| 05/11/2006 | WO2006026458A3 Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle |
| 05/11/2006 | WO2006023408A3 Method of customizing the fragrance of nasal medications |
| 05/11/2006 | WO2005120473A3 Dermal peel-forming formulation |
| 05/11/2006 | WO2005116212A3 Treatment of neurodegenerative disease through intracranial delivery of sirna |
| 05/11/2006 | WO2005112887A3 Composition comprising intercalated functional-active organic compounds |
| 05/11/2006 | WO2005110439A3 Stabilized hyaluronan preparations and related methods |
| 05/11/2006 | WO2005105061A3 Transdermal patch |
| 05/11/2006 | WO2005102275B1 Galantamine salts, method of producing it and nasal composition thereof |
| 05/11/2006 | WO2005094784A3 Bifunctional bioadhesive compositions for oral implantology |
| 05/11/2006 | WO2005089728A3 Means for transdermal administration of nicotine |
| 05/11/2006 | WO2005079753A3 Extended release pharmaceutical compositions of divalproex sodium |
| 05/11/2006 | WO2005072397A3 Gastrointestinal-specific multiple drug release system |
| 05/11/2006 | WO2005065713A3 Topically applied medicament for animals |
| 05/11/2006 | WO2005065644A3 Drug delivery device with mesh based suture tab |
| 05/11/2006 | WO2005065642A3 Drug delivery device |
| 05/11/2006 | WO2005065185A3 Temperature-stable formulations, and methods of development thereof |
| 05/11/2006 | WO2005034912A3 Ferromagnetic particles and methods |
| 05/11/2006 | WO2004110381A3 Pharmaceutical compositions comprising active vitamin d compounds |